An Exploratory Trial Investigating the Safety and Efficacy of Fast-acting Insulin Aspart in a Closed-loop Insulin Delivery System (Bionic Pancreas) in Adults With Type 1 Diabetes
Latest Information Update: 04 Nov 2021
At a glance
- Drugs Insulin aspart (Primary)
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Novo Nordisk
Most Recent Events
- 25 Sep 2020 Results presented at the 56th Annual Meeting of the European Association for the Study of Diabetes
- 19 Jun 2019 Status changed from recruiting to completed.
- 07 Mar 2019 Planned End Date changed from 25 Apr 2019 to 24 May 2019.